ArmaGen Technologies Company
%20.jpg)
ArmaGen is a developer of therapies designed to address neurological complications. The company's pipeline of innovative therapies penetrate the blood-brain barrier to treat neurological complications of many diseases, including lysosomal storage disorders (LSDs), Alzheimer's and Parkinson's, enabling patients suffering from neurodegenerative disorders to get improved treatment.
Technology:
NeuroTech
Headquarters:
Santa Monica, California, United States
Funding Status:
M&A
Founded Date:
2001-01-01
Last Funding Type:
Undisclosed
Investors Number:
4
Estimated Revenue:
$1M to $10M
Employee Number:
11-50
Total Funding:
$35.5M
Industry:
Biotechnology, Health Care, Medical
Investor Type:
For Profit